Clinical TrialsSearch results
Number of results: 266
Other
- Phase 2 study of G-CSF priming chemotherapy for high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- Expanded Treatment Efficacy and Safety Study of Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Epirubicin/ Doxorubicin-Lipiodol Emulsion and Gelatin Particles: Korea-Japan Cooperative Study (JIVROSG-0604)
- hepatocellular carcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-01-08
Other
- Japanease multi-center clinical trial to assess the inhibitory effects of branched chain amino acids on the recurrence after curative treatment of hepatocellular carcinoma
- Hepatocellular carcinoma
- Ministry of Health, Labour and Welfare
- 2009-08-12
Other
- JPLT2 protocol (CITA and ITEC regimen)for the pediatric liver tumor in Japan
- hepatoblastoma hepatocellular carcinoma
- Japanese Study Group for Pediatric Liver Tumors
- 2008-04-09
Other
- Clinical phase II study of double-unit cord blood transplantation for hematological malignancies.(C-SHOT 0507)
- Hematological malignancies
- A Research Grant on Human Genome, Tissue Engineering from the Japanese Ministry of Health, Labor & Welfare: Research on advancement and safety security of HSCT using umbilical cord blood.
- 2006-03-15
Recruiting
- Effects of Enalodustat on Heart Failure Patients with Renal Anemia
- Heart failure with renal anemia
- Mima Akira
- 2024-04-10
Recruiting
- Pilot trial of Codonopsis lanceolata
- Healthy volunteers
- Tamaru Satoshi
- 2024-03-01
Not yet recruiting
- Analysis of the effects of oral movement and temperature on mucosal blood flow
- healthy adults decrease in oral mucosal blood flow
- Shimizu Kasumi
- 2021-10-05
Not yet recruiting
- The effect of blood flow during lip cooling
- Healthy adults decrease in oral mucosal blood flow
- Shimizu Kasumi
- 2024-01-18
Completed
- Fasudil trial phase 1 study(FAS1)
- Healthy
- Okamoto Ryuji
- 2022-02-14